These agents protected the heart from I/R injuries when applied prior to ischemia, and the protection was attenuated by co-administration of toxins, such as paxilline, inhibiting BK, thereby strongly supporting the notion that pro-survival pathways promote BK activity. Here, KNG1 is linked to ischemia.